Abstract:In the tumor microenvironment, chemokine system has a critical role in tumorigenesis and metastasis. The acquisition of stem-like properties by cancer cells is involved in metastasis and drug resistance, which are pivotal problems that result in poor outcomes in patients with lung cancer. Patients with advanced lung cancer present high plasma levels of transforming growth factor-β1 (TGFβ1), which correlate with poor prognostic features. Therefore, TGFβ1 may be important in the tumor microenvironment, where chemokines are widely expressed. However, the role of chemokines in TGFβ1-induced tumor progression still remains unclear. In our study, TGFβ1 upregulated CXC chemokine receptor expression, migration, invasion, epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) formation in lung adenocarcinoma. We found that CXCR7 was the most upregulated chemokine receptor induced by TGFβ1. CXCR7 knockdown resulted in reduction of migration, invasion and EMT induced by TGFβ1, whereas CXCR4 knockdown did not reverse TGFβ1-promoted EMT. CXCR7 silencing significantly decreased cancer sphere-forming capacity, stem-like properties, chemoresistance and TGFβ1-induced CSC tumor initiation in vivo. In clinical samples, high TGFβ1 and CXCR7 expression was significantly associated with the late stages of lung adenocarcinoma. Moreover, TGFβ1 and CXCR7 coexpression was positively correlated with the CSC marker, CD44, which is associated with lymph node metastasis. Besides, patients with high expression of both CXCR7 and TGFβ1 presented a significantly worse survival rate. These results suggest that the TGFβ1-CXCR7 axis may be a prognostic marker and may provide novel targets for combinational therapies to be used in the treatment of advanced lung cancer in the future.

CXCR7 in tumorigenesis and progression.

Effect of CXCR7 on Tumor Development,Angiogenesis and Immune Reaction

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

CXCR7 in the Happening and Development of Diseases

Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer

The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment

The Role of CXCR3 and Its Ligands in Cancer

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

The Role of Cxc Chemokines and Their Receptors in the Progression and Treatment of Tumors

The chemokine receptors CXCR4 and CXCR7 in cancer

The Advances in Chemokine Receptors CXCR1/2 and Cancer

Chemokines and their role in tumor growth and metastasis

Crucial Biological Functions of CCL7 in Cancer

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications

Dual attribute of CXCR7 and its role in tumors

The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets

CXCR7 Promotes Melanoma Tumorigenesis Via Src Kinase Signaling

CXCR7 As a Chemokine Receptor for SDF-1 Promotes Gastric Cancer Progression Via MAPK Pathways.

CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer

Chemokine-chemokine Receptor Pathway As a Tumor Therapeutic Target: the Significance of SDF-1CXCR4 Pair

CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer